About this trial
Lifestyle modifications, including dietary changes and increased physical activity, play a crucial role in controlling complications to reduce or eliminate them. As well as controlling disturbances in biochemical markers such as DNAm PhenoAge, and signs of aging such as circulating sclerostin (SOST) and growth differentiation factor 15 (GDF15). This study seeks to address this dilemma by focusing on specific groups of elderly Saudis with prediabetes . Lifestyle changes in elderly Saudis with prediabetes show promise in reducing or eliminating complications. The potential insights derived from this research extend beyond academia, offering tangible benefits for clinical practice and public health
The proposed study will be implemented to achieve the following objective:
1. To determine changes in DNAm PhenoAge of elderly Saudis with prediabetes who underwent a 6-month lifestyle modification program. 2. To determine changes in other candidate senescence markers such as circulating sclerostin (SOST) and growth differentiation factor 15 (GDF15) of elderly Saudis with prediabetes who underwent a 6-month lifestyle modification program.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Clinical diagnosis of pre-diabetes for all Saudis aged 30 years and above, males and females
They must be able to exercise and be able to follow a diet
Disqualifiers
Insulin-dependent diabetes and non-diabetic patients
People with diseases that prevent them from participating and doing exercises
Trial design
Parallel
Treatments tested in this trial
Providing nutritional counselling
Other interventionDietary counseling and monitoring: Reduce fat intake (30% of total energy and saturated fat 10% of total energy) and increase fiber intake (15 g/1000 kcal) in the diet. Participants will receive individual, detailed, ongoing nutritional counseling by the study dietitian every two weeks.
counseling on physical activity
Other interventionPhysical activity: Participants will also be encouraged to participate in physical activities. moderate exercise (150 minutes/week)
Treatment groups
Trial outcomes
Primary outcomes
Change in the rate of measurements of Age marker Albumin post intervention
Change in Albumin (g/L)
Change in the rate of measurements of Age marker fasting glucose post intervention
Change in fasting glucose (mmol/L)
Change in the rate of measurements of Age marker Creatinine post intervention
Change in Creatinine (umol/L)
Change in the rate of measurements of Age marker C-Reactive Protein post intervention
Change in C-Reactive Protein (mg/dL)
Secondary outcomes
Change in the rate of measurements of Age marker SOST post intervention
Change in SOST(pmol/L)
Change in the rate of measurements of Age marker GDF15 post intervention
Change in GDF15 (10\^3 pg/mL)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: